Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for alveolar bone healing after tooth extraction
RBR-66tbzr4Completed
- Sponsor
- Universidade Federal Fluminense
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, triple-blind trial of teriparatide in alveolar bone healing (2 arms), sponsored by Universidade Federal Fluminense. Primary endpoint: Alveolar bone healing at 90 days. Started May 2022; status: completed.
02
Drugs
teriparatide
03
Conditions
alveolar bone healing
Beyond the preview
Go deeper on RBR-66tbzr4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-66tbzr4.